Single cell and lineage tracing studies reveal the impact of CD34(+) cells on myocardial fibrosis during heart failure

BACKGROUND: CD34(+) cells have been used to treat the patients with heart failure, but the outcome is variable. It is of great significance to scrutinize the fate and the mechanism of CD34(+) cell differentiation in vivo during heart failure and explore its intervention strategy. METHODS: We perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Luping, Sun, Xiaotong, Gong, Hui, Wang, Ting, Jiang, Liujun, Huang, Chengchen, Xu, Xiaodong, Li, Zhoubin, Xu, Hongfei, Ma, Liang, Li, Weidong, Chen, Ting, Xu, Qingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942332/
https://www.ncbi.nlm.nih.gov/pubmed/36805782
http://dx.doi.org/10.1186/s13287-023-03256-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942332/
https://www.ncbi.nlm.nih.gov/pubmed/36805782
http://dx.doi.org/10.1186/s13287-023-03256-0

Ejemplares similares